MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
45
Registration Number
NCT00000827
Locations
🇺🇸

Usc La Nichd Crs, Los Angeles, California, United States

🇺🇸

Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy, Los Angeles, California, United States

🇺🇸

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States

and more 36 locations

A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 2
Completed
Conditions
Sarcoma, Kaposi
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
48
Registration Number
NCT00000996
Locations
🇺🇸

Univ of Miami School of Medicine, Miami, Florida, United States

🇺🇸

UCLA CARE Ctr, Los Angeles, California, United States

🇺🇸

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

and more 9 locations

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
168
Registration Number
NCT00000755
Locations
🇺🇸

UCLA CARE Center CRS, Los Angeles, California, United States

🇺🇸

Stanford CRS, Palo Alto, California, United States

🇺🇸

Ucsf Aids Crs, San Francisco, California, United States

and more 7 locations

A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS

Phase 2
Completed
Conditions
HIV Infections
Histoplasmosis
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
30
Registration Number
NCT00000975
Locations
🇺🇸

USC CRS, Los Angeles, California, United States

🇺🇸

Northwestern University CRS, Chicago, Illinois, United States

🇺🇸

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States

and more 9 locations

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

Phase 2
Completed
Conditions
HIV Infections
Peripheral Nervous System Disease
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
270
Registration Number
NCT00000842
Locations
🇺🇸

UCLA CARE Center CRS, Los Angeles, California, United States

🇺🇸

Northwestern University CRS, Chicago, Illinois, United States

🇺🇸

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

and more 11 locations

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
1292
Registration Number
NCT00000781
Locations
🇺🇸

Beth Israel Deaconess - West Campus, Boston, Massachusetts, United States

🇺🇸

Univ of Pennsylvania at Philadelphia, Philadelphia, Pennsylvania, United States

🇵🇷

Univ of Puerto Rico, San Juan, Puerto Rico

and more 93 locations

A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

Phase 1
Completed
Conditions
HIV Infections
Sarcoma, Kaposi
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
36
Registration Number
NCT00000987
Locations
🇺🇸

UCLA CARE Center CRS, Los Angeles, California, United States

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Phase 2
Completed
Conditions
Cytomegalovirus Retinitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
156
Registration Number
NCT00000691
Locations
🇺🇸

USC CRS, Los Angeles, California, United States

🇺🇸

Univ. of Miami AIDS CRS, Miami, Florida, United States

🇺🇸

Ucsf Aids Crs, San Francisco, California, United States

and more 8 locations

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Phase 2
Completed
Conditions
Cryptosporidiosis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
68
Registration Number
NCT00000771
Locations
🇵🇷

Puerto Rico-AIDS CRS, San Juan, Puerto Rico

🇺🇸

USC CRS, Los Angeles, California, United States

🇺🇸

Univ. of Miami AIDS CRS, Miami, Florida, United States

and more 12 locations

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

Phase 2
Completed
Conditions
AIDS Dementia Complex
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
80
Registration Number
NCT00000657
Locations
🇺🇸

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

🇺🇸

San Francisco Gen Hosp, San Francisco, California, United States

🇺🇸

Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States

and more 10 locations
© Copyright 2025. All Rights Reserved by MedPath